Document Detail

PRODIACOR: a patient-centered treatment program for type 2 diabetes and associated cardiovascular risk factors in the city of Corrientes, Argentina: study design and baseline data.
MedLine Citation:
PMID:  17331807     Owner:  NLM     Status:  MEDLINE    
OBJECTIVE: To implement a controlled clinical trial (PRODIACOR) in a primary care setting designed 1) to improve type 2 diabetes care and 2) to collect cost data in order to be able to measure cost-effectiveness of three system interventions (checkbook of indicated procedures, patient/provider feedback and complete coverage of medications and supplies) and physician and/or patient education to improve psychological, clinical, metabolic and therapeutic indicators. All three Argentinean health subsectors (public health, social security and the private, prepaid system) are participants in the study. Patients of participating physicians were randomly selected and assigned to one of four groups: control, provider education, patient education, and provider/patient education; the system interventions were provided to all four groups.
BASELINE RESULTS: Mean BMI was 29.8 kg/m(2); most subjects had blood pressure, fasting glucose and total cholesterol above targets recommended by international standards. Only 1% had had microalbuminuria measured, 57% performed glucose self-monitoring, 37% had had an eye examination and 31% a foot examination in the preceding year. Ten percent, 26% and 73% of people with hyperglycemia, hypertension and dyslipidemia, respectively, were not on medications. Most patients treated with either insulin or oral antidiabetic agents were on monotherapy as were those treated for hypertension and dyslipidemia. WHO-5 questionnaire scores indicated that 13% of the subjects needed psychological intervention.
CONCLUSIONS: Baseline data show multiple deficiencies in the process and outcomes of care that could be targeted and improved by PRODIACOR intervention.
J J Gagliardino; S Lapertosa; M Villagra; J E Caporale; P Oliver; C Gonzalez; F Siri; Ch Clark;
Related Documents :
21059457 - Improving construction site safety through leader-based verbal safety communication.
17331807 - Prodiacor: a patient-centered treatment program for type 2 diabetes and associated card...
11449807 - Attachment and depression. implications for family therapy.
14594917 - Cognitive-behavioural therapy and motivational intervention for schizophrenia and subst...
20491747 - Clinical trial: impact of prior infliximab therapy on the clinical response to certoliz...
12719677 - Common complementary and alternative therapies for yeast vaginitis and bacterial vagino...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2007-01-12
Journal Detail:
Title:  Contemporary clinical trials     Volume:  28     ISSN:  1551-7144     ISO Abbreviation:  Contemp Clin Trials     Publication Date:  2007 Jul 
Date Detail:
Created Date:  2007-05-21     Completed Date:  2007-08-17     Revised Date:  2014-11-13    
Medline Journal Info:
Nlm Unique ID:  101242342     Medline TA:  Contemp Clin Trials     Country:  United States    
Other Details:
Languages:  eng     Pagination:  548-56     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Body Mass Index
Cardiovascular Diseases / therapy*
Data Collection / statistics & numerical data
Diabetes Mellitus, Type 2 / therapy*
Health Status Indicators
Inservice Training
Middle Aged
Patient Education as Topic
Patient Satisfaction
Patient-Centered Care*
Primary Health Care
Quality Assurance, Health Care
Randomized Controlled Trials as Topic / methods*,  statistics & numerical data
Reminder Systems
Research Design
Risk Factors
Sample Size

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Incidence of gastroenterostomy stenosis in laparoscopic Roux-en-Y gastric bypass using 21- or 25-mm ...
Next Document:  Methods of joint evaluation of efficacy and toxicity in phase II clinical trials.